胃肠非肿瘤性与肿瘤性疾病患者静脉血栓栓塞症的长期风险:484 211 名个体的前瞻性队列研究
基于英国生物银行 485 936 名基线无静脉血栓栓塞症(VTE)参与者的前瞻性队列研究,中位随访 12.0 年确诊 13 646 例新发 VTE。经 Bonferroni 校正后,11 种胃肠道疾病(9 种非肿瘤性、2 种肿瘤性)与新发 VTE 风险升高相关;胆囊及胆道癌、胰腺癌、肝硬化、克罗恩病、胰腺炎患者 VTE 风险升高超过 50%。
要点
- 中位随访 12.0 年,485 936 名参与者中确诊 13 646 例新发 VTE。
- 11 种胃肠道疾病经 Bonferroni 校正后与新发 VTE 风险升高相关。
- 胆囊及胆道癌、胰腺癌、肝硬化、克罗恩病、胰腺炎患者 VTE 风险升高超过 50%。
核心结论
- 研究提示,胆囊及胆道癌、胰腺癌、肝硬化、克罗恩病或胰腺炎患者发生 VTE 的风险升高 50%。
研究设计与样本
- 前瞻性队列研究,纳入英国生物银行 485 936 名基线无 VTE 的参与者。
- 胃肠道疾病依据国际疾病分类(ICD)-9 和 10 编码,数据来自全国住院数据集、初级保健数据集和癌症登记处。
- 新发 VTE 依据 ICD-9 和 10 编码,数据来自全国住院数据集。
- 采用 Cox 比例风险回归估计基线胃肠道疾病与新发 VTE 风险的关联。
主要发现
- 中位随访 12.0 年,共诊断 13 646 例新发 VTE。
- 经 Bonferroni 校正后,11 种胃肠道疾病(9 种非肿瘤性、2 种肿瘤性)与新发 VTE 风险升高相关。
- 与无相应疾病者相比,胆囊及胆道癌患者 VTE 风险 HR 3.15(95%CI 1.74-5.70)。
- 与无相应疾病者相比,胰腺癌患者 HR 2.84(95%CI 1.65-4.91),肝硬化患者 HR 2.34(95%CI 1.96-2.79)。
- 与无相应疾病者相比,克罗恩病患者 HR 1.61(95%CI 1.33-1.95),胰腺炎患者 HR 1.57(95%CI 1.31-1.88)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We conducted a prospective cohort study to examine the associations of 21 gastrointestinal diseases with the risk of incident venous thromboembolism (VTE). The study included 485 936 UK Biobank participants free of baseline VTE. The gastrointestinal diseases were defined by the International Classification of Disease (ICD)-9 and 10 codes with data from the nationwide inpatient data set, the primary care data set, and the cancer registries. Incident VTE cases were defined by ICD-9 and 10 codes with data from the nationwide inpatient data set. Cox proportional hazards regression was used to estimate the associations of baseline gastrointestinal diseases with incident VTE risk. During a median follow-up of 12.0 years, 13 646 incident VTE cases were diagnosed. Eleven gastrointestinal diseases (nine non-neoplastic and two neoplastic) were associated with an increased risk of incident VTE after Bonferroni corrections. The risk of VTE was >50% higher among patients with gallbladder and biliary tract cancer (hazard ratio [HR] 3.15, 95% confidence interval [CI] 95% CI 1.74-5.70), pancreatic cancer (HR 2.84, 95% CI 1.65-4.91), cirrhosis (HR 2.34, 95% CI 1.96-2.79), Crohn's disease (HR 1.61, 95% CI 1.33-1.95), or pancreatitis (HR 1.57, 95% CI 1.31-1.88) compared with individuals without each of these diseases. We observed multiplicative interactions of age, sex, and body mass index with some gastrointestinal diseases (p < .05). A more pronounced, increased risk of VTE was found among younger, female, or obese patients. The study suggests a 50% higher risk of developing VTE among patients with gallbladder and biliary tract cancer, pancreatic cancer, cirrhosis, Crohn's disease, or pancreatitis.
引用
- Yuan S, Sun Y, Chen J, et al. Long-term risk of venous thromboembolism among patients with gastrointestinal non-neoplastic and neoplastic diseases: A prospective cohort study of 484 211 individuals. Am J Hematol. 2023. PMID: 37753710. doi:10.1002/ajh.27106
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。